Exciting Times in Cancer Research!

Join CURE ID and contribute your report now: cure.ncats.io 

#MIBAgents #MakeItBetter #osteosarcoma #CUREID #research

"Barnard organization is dedicated to ‘making it better’ for those battling osteosarcoma"

Read Ann Graham's full article with The Vermont Standard here: thevermontstandard.com/barnard-orga...

Thank you, Ann and The Vermont Standard, for Making It Better!

#MIBAgents #MakeItBetter #osteosarcoma

Thursday, we were joined by Joseph Skeate, PhD, on OsteoBites to discuss, “Next generation dual-CAR gamma delta T cells for the treatment of pediatric osteosarcoma”.

Watch the full episode here: youtu.be/wiR88fM3Row?...

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

URGENT!

Find your senators: www.senate.gov/senators/sen...

Every call. Every email. Every voice matters. Let’s give kids a fighting chance.

#MIBAgents #MakeItBetter #osteosarcoma #GiveKidsAChance #ChildhoodCancerAwareness #AdvocateForKids #PassTheBill

URGENT: The Senate votes soon on the Mikaela Naylon Give Kids a Chance Act, which could expand treatment options for kids with cancer. Contact your two senators this week and urge a YES vote. Let’s give kids a fighting chance. www.congressweb.com/kvc/14/

Thursday, we were joined by Isidro Cortés-Ciriano, PhD, on OsteoBites to discuss, "Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution".

Watch the full episode here: www.youtube.com/watch?v=H1kV...

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

MIB Agents is sad to share of the passing of Dr. Brian A. Van Tine, MD.

Thank you, Dr. Van Tine, for Making It Better. Our thoughts and hearts go out to all affected.

Thursday, we were joined by Janeala Morsby, PhD on OsteoBites to discuss, "Synergy of ATM and PARP Inhibitors in Pediatric Osteosarcoma".

Watch the full episode here: www.youtube.com/watch?v=c6qX...

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

OutSmarting Osteosarcoma 2026!

The Letter of Intent (LOI) submission period will open on September 24, 2025. LOIs are due by October 24, 2025 at 11:59pm ET. Approved LOI applicants will be invited to submit full applications by January 25, 2026.

#MIBAgents #MakeItBetter

Thursday, we were joined by Alanna Church, MD, on OsteoBites to discuss, "Insights from the AACR Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer".

Watch the full episode here: www.youtube.com/watch?v=1_2X...

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites

Thursday, we were joined by Amy Armstrong, MD, on OsteoBites!

Watch the full episode here: www.youtube.com/watch?v=GMkS...

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

Thursday, we were joined by Yanding Zhao, PhD, on OsteoBites to discuss, "Distinct patterns of chromosomal instability fuel osteosarcoma progression and influence patient outcomes".

Watch the full episode here: www.youtube.com/watch?v=1UxJ...

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites

Thursday, we were joined by Brian Ladle, MD, PhD on OsteoBites to discuss, "Deciphering the impact of STING agonists on the tumor microenvironment in osteosarcoma".

Watch the full episode here: www.youtube.com/watch?v=GzZ6...

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

Thursday, we were joined by Amanda Marinoff, MD on OsteoBites to discuss, "Clinical biomarkers for osteosarcoma stratification (cBOSS): Insights from a working group".

Watch the full episode here: www.youtube.com/watch?v=aDjq...

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites